Literature DB >> 16173957

Reducing adverse events in blood transfusion.

Dorothy Stainsby1, Joan Russell, Hannah Cohen, John Lilleyman.   

Abstract

Against a background of ever increasing expenditure on blood safety, less attention has been paid to improving the safety of the transfusion chain within hospitals. Based on reports to the Serious Hazards of Transfusion (SHOT scheme) between 1996 and 2003, the risk of an error occurring during transfusion of a blood component is estimated at 1:16 500, an ABO incompatible transfusion at 1:100 000 and the risk of death as a result of an 'incorrect blood component transfused' (IBCT) is around 1:1 500 000. There are opportunities for error at a number of critical points in the transfusion chain, starting with the decision to transfuse, prescription and request, patient sampling, pretransfusion testing and finally the collection of the component from the blood refrigerator and administration to the patient, consistently the commonest error in successive SHOT reports. Successive 'Better Blood Transfusion' initiatives and the 2003 Annual Report of the Chief Medical Officer for England have drawn welcome attention to the importance of safe and appropriate transfusion and the National Patient Safety Agency has now set a target of reducing the number of ABO incompatible transfusions by 50% over 3-5 years.

Entities:  

Mesh:

Year:  2005        PMID: 16173957     DOI: 10.1111/j.1365-2141.2005.05702.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  18 in total

1.  Case report: The management of advanced oral cancer in a Jehovah's Witness using the Ultracision Harmonic Scalpel.

Authors:  Peter J Kullar; Kristian Sorenson; Ruwan Weerakkody; James Adams
Journal:  World J Surg Oncol       Date:  2011-10-03       Impact factor: 2.754

2.  The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.

Authors:  Francesco Bennardello; Carmelo Fidone; Vincenzo Spadola; Sergio Cabibbo; Simone Travali; Giovanni Garozzo; Agostino Antolino; Giuseppe Tavolino; Cadigia Falla; Pietro Bonomo
Journal:  Blood Transfus       Date:  2013-05-21       Impact factor: 3.443

3.  Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity.

Authors:  María Jose Uríz; Maria Luisa Antelo; Saioa Zalba; Nazaret Ugalde; Esther Pena; Andrea Corcoz
Journal:  Blood Transfus       Date:  2011-01-17       Impact factor: 3.443

4.  Reporting System in Transfusion Medicine - a Contribution to Patient Safety in the CLINOTEL Hospital Group.

Authors:  Andreas Becker; Frank Thölen
Journal:  Transfus Med Hemother       Date:  2010-05-25       Impact factor: 3.747

5.  After Hour Blood Transfusions: A Transfusion Service Perspective.

Authors:  Dhivya Kandasamy; Shamee Shastry; Ganesh Mohan; Chenna Deepika
Journal:  Indian J Hematol Blood Transfus       Date:  2018-10-01       Impact factor: 0.900

6.  The State and Trends of Barcode, RFID, Biometric and Pharmacy Automation Technologies in US Hospitals.

Authors:  Raymonde Charles Y Uy; Fabricio P Kury; Paul A Fontelo
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

7.  Use of an identification system based on biometric data for patients requiring transfusions guarantees transfusion safety and traceability.

Authors:  Francesco Bennardello; Carmelo Fidone; Sergio Cabibbo; Salvatore Calabrese; Giovanni Garozzo; Grazia Cassarino; Agostino Antolino; Giuseppe Tavolino; Nuccio Zisa; Cadigia Falla; Giuseppe Drago; Giovanna Di Stefano; Pietro Bonomo
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

8.  Red blood cell transfusion in the critically ill patient.

Authors:  Christophe Lelubre; Jean-Louis Vincent
Journal:  Ann Intensive Care       Date:  2011-10-04       Impact factor: 6.925

9.  Quality standards and samples in genetic testing.

Authors:  David Ravine; Graeme Suthers
Journal:  J Clin Pathol       Date:  2012-01-18       Impact factor: 3.411

10.  Comparison between Prothrombin Complex Concentrate (PCC) and Fresh Frozen Plasma (FFP) for the Urgent Reversal of Warfarin in Patients with Mechanical Heart Valves in a Tertiary Care Cardiac Center.

Authors:  Bahram Fariborz Farsad; Reza Golpira; Hamideh Najafi; Ziae Totonchi; Shirin Salajegheh; Hooman Bakhshandeh; Farshad Hashemian
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.